Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Cardiac Repair

NACompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

August 15, 2017

Primary Completion Date

November 15, 2020

Study Completion Date

February 15, 2024

Conditions
Heart Diseases
Interventions
PROCEDURE

Open heart surgery to address the heart disease

The patient will first have open heart surgery to achieve access to the diseased site in the heart

DEVICE

Close the defects with XenoSure Patch

The heart defects, such as ASD (Atrial Septal Defect) or VSD (Ventricular Septal Defect ), are closed with LeMaitre XenoSure Patch.

DEVICE

Close the defects with Chest Polyester Patch

The heart defects, such as ASD (Atrial Septal Defect) or VSD (Ventricular Septal Defect ), are closed with a Polyester Patch made by Shanghai Chest Medical Technology Co.

Trial Locations (1)

100853

Chinese PLA General Hospital, Beijing

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LeMaitre Vascular

INDUSTRY